Veru CEO: Cancer drug has potential to prevent Covid-19 deaths
Published February 9, 2021
Views 6.56K | Likes 81 | Comments 15
At a glance
Views
6,560
Likes
81
Comments
15
Performance vs. channel
Outlier score
Engagement rate
More features coming
We're working on new analytics and tools. Stay tuned.
About
Veru CEO Dr. Mitchell Steiner explained how VERU-111, a prostate cancer drug developed by the biotech company, could be used as an anti-inflammatory and antiviral treatment to help patients diagnosed with the novel coronavirus. Subscribe to CNBC PRO for access to investor and analyst insights: https://cnb.cx/2Vtntx6 …
- Published
- February 9, 2021
- Made for kids
- No
More features coming
We're working on new analytics and tools. Stay tuned.